Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DPP4 | P27487 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.34 |
| ▸ | HTT | P42858 | 1/20 | 0.34 |
| ▸ | CES2 | O00748 | 1/20 | 0.31 |
| ▸ | CES1 | P23141 | 1/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
| ▸ | DAO | P14920 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9815889 | 0.86 | CES2 (0.40) | ALDH1A1HSD17B10CES2CES1 | |
| SCHEMBL6740928 | 0.85 | HTT (0.32) | DPP4ALDH1A1KDM4EHSD17B10HTT | |
| SCHEMBL4899263 | 0.83 | DPP4 (0.43) | DPP4ALDH1A1KDM4EHSD17B10HTT | |
| SCHEMBL70425 | 0.83 | DPP4 (0.43) | DPP4ALDH1A1KDM4EHSD17B10HTT | |
| SCHEMBL28622150 | 0.82 | KDM4E (0.33) | DPP4ALDH1A1KDM4EHSD17B10HTT | |
| SCHEMBL162169 | 0.80 | CA12 (0.41) | ALDH1A1KDM4EHSD17B10HTTSMN1; SMN2 | |
| Dacthal SCHEMBL8539721 | 0.80 | CA12 (0.41) | ALDH1A1KDM4EHSD17B10HTTSMN1; SMN2 | |
| SCHEMBL7882999 | 0.80 | HTT (0.32) | DPP4ALDH1A1KDM4EHSD17B10HTT | |
| SCHEMBL205832 | 0.80 | HTT (0.45) | DPP4ALDH1A1KDM4EHSD17B10HTT | |
| Hydrochloric Acid SCHEMBL11671966 | 0.80 | DPP4 (0.42) | DPP4ALDH1A1KDM4EHSD17B10HTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7112369-B2 | Nano-sized polymer-metal composites | BRIDGESTONE CORPORATION (JP) | 2006-09-26 | — | — | US | claimed |
| US-20060083926-A1 | NANO-SIZED POLYMER-METAL COMPOSITES | BRIDGESTONE CORPORATION (JP) | 2006-04-20 | — | — | US | claimed |
| JP-62260871-A | — | — | None | — | — | JP | disclosed |
| US-7626028-B2 | Use of quinaldine and naphthaline derivatives as crystallisation modifiers | BASF AKTIENGESELLSCHAFT (DE) | 2009-12-01 | — | — | US | disclosed |
| US-7112369-B2 | Nano-sized polymer-metal composites | BRIDGESTONE CORPORATION (JP) | 2006-09-26 | — | — | US | disclosed |
| US-20060150866-A1 | Use of quinaldine and naphthaline derivatives as crystallisation modifiers | BASF AKTIENGESSELLSCHAFT (DE) | 2006-07-13 | — | — | US | disclosed |
| US-20060083926-A1 | NANO-SIZED POLYMER-METAL COMPOSITES | BRIDGESTONE CORPORATION (JP) | 2006-04-20 | — | — | US | disclosed |
| JP-S62260871-A | RESIN COMPOSITION FOR POWDER COATING | DAINIPPON INK & CHEM INC | 1987-11-13 | — | — | JP | disclosed |
| US-4022817-A | Esters prepared from diacylium complexes of tetrahaloterephthalic acid | STANDARD OIL COMPANY (INDIANA) (US) | 1977-05-10 | — | — | US | disclosed |
| US-3953481-A | Diacylium complexes of tetrahaloterephthalic acid | STANDARD OIL COMPANY (US) | 1976-04-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060150866-A1 | Use of quinaldine and naphthaline derivatives as crystallisation modifiers | CBR3, CYB5R3, CBR1 | DPP4 4618/4885ALDH1A1 2306/4885KDM4E 4210/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.